Search Results - "Buchholcz, Gyula"

  • Showing 1 - 7 results of 7
Refine Results
  1. 1
  2. 2

    Evolution of the Gram-Negative Antibiotic Resistance Spiral over Time: A Time-Series Analysis by Tóth, Hajnalka, Buchholcz, Gyula, Fésüs, Adina, Balázs, Bence, Nagy, József Bálint, Majoros, László, Szarka, Krisztina, Kardos, Gábor

    Published in Antibiotics (Basel) (17-06-2021)
    “…We followed up the interplay between antibiotic use and resistance over time in a tertiary-care hospital in Hungary. Dynamic relationships between monthly…”
    Get full text
    Journal Article
  3. 3
  4. 4

    Evaluation of the swelling behaviour of iota-carrageenan in monolithic matrix tablets by Kelemen, András, Buchholcz, Gyula, Sovány, Tamás, Pintye-Hódi, Klára

    “…•The swellable matrices have become a popular solid dosage form for controlled release drug delivery systems.•Study of the swelling behaviour of these systems…”
    Get full text
    Journal Article
  5. 5

    Modified-release capsules containing sodium riboflavin 5′-phosphate by Buchholcz, Gyula, Kelemen, András, Pintye-Hódi, Klára

    Published in Drug development and industrial pharmacy (01-12-2014)
    “…Abstract Introduction: The focus of this work was to produce delayed-release capsules containing riboflavin (vitamin B2, as API) layered pellets. Riboflavin…”
    Get full text
    Journal Article
  6. 6

    Development and Characterization of Modified Release Oral Preparations Containing Riboflavin by Buchholcz, Gyula

    Published 01-01-2015
    “…The vitamins essential for living organisms are normally consumed in small amounts with the food. These organic materials facilitate the biochemical reactions…”
    Get full text
    Dissertation
  7. 7

    Matrix tablets based on a carrageenan with the modified-release of sodium riboflavin 5′-phosphate by Buchholcz, Gyula, Kelemen, András, Sovány, Tamás, Pintye-Hódi, Klára

    Published in Pharmaceutical development and technology (01-01-2015)
    “…The focus of this work was to produce modified-release monolithic matrix tablets containing sodium riboflavin 5′-phosphate (vitamin B 2 ) as active…”
    Get full text
    Journal Article